Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-25
1997-05-20
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530328, A61K 3800, C07K 700, C07K 706
Patent
active
056312300
ABSTRACT:
Analogues of cholecystokinin-8, which are receptor selective, vary from the normal hormone by alteration of at least one of the two, three or six position amino acids of the natural sequence.
REFERENCES:
patent: 4400377 (1983-08-01), Zetler et al.
Hruby et al, Peptides, 1990, 707-709.
Durieux, et al, vol. 137, Biochemical and Biophysical Research Communication, pp. 1167-1173 (1986).
Sawyer, et al, Abstract, Neural Endocr. Pept. Recept. 5th (1986), pp. 541-552.
Wire et al, Proc. West. Pharmacol. Soc., 33, 65-68, (1990).
Knapp et al, Pharmacology and Experimental Therapeutics, vol. 255, No. 3, 1278-86. 1990.
Wire et al, Proc. West Pharmacol Soc. 34, 453-459 (1991).
Ayres, et al, Proc. West Pharmacol Soc. 34: 477-484, 1991.
Knapp et al, J. of Pharmacology, 191-98, 1991.
Fang Sunan
Hruby Victor
Arizona Technology Development Corporation
Marshall S. G.
Tsang Cecilia J.
LandOfFree
Receptor selective analogues of cholecystokinin-8 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor selective analogues of cholecystokinin-8, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor selective analogues of cholecystokinin-8 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1723921